How China Built A State Venture System India Cannot Ignore
Beijing has constructed the largest state-directed venture capital apparatus in history — 2,178 funds, $900 billion raised, and…
China’s ‘landmark’ drug pricing guidelines widen biotech profit window: analysts
The State Council, China’s cabinet, has published guidelines on innovative drug pricing that a bank analyst has described…
China ramps up hunt for tax evaders, frames consumption levies as fiscal lifelines
Beijing is intensifying its enforcement against tax evasion, extending its reach into consumption taxes, which have been positioned…
Will China’s deal with Australian mining giant BHP boost yuan internationalisation?
Australian mining giant BHP’s decision to adopt a yuan-denominated index for a major Chinese buyer poses a challenge…
Shell Book Pavilion / LUO studio
© Yumeng Zhu + 32 Share Share Facebook Twitter Mail Pinterest Whatsapp Or https://www.archdaily.com/1040851/shell-book-pavilion-luo-studio Area Area of this…
China to fuse software and steel with US$14tr sector to fix weak links in world’s factory
China is embarking on a sweeping overhaul of its industrial architecture, aiming to fuse software and steel as…
As the Hormuz crisis exposes ‘fragile’ global supply chains, how will China respond?
The chief of China’s top economic planner has outlined strategies and priorities to safeguard economic security, as Beijing…
China ships more humanoid robots than the U.S.
A staff member trains a humanoid robot to replicate human behavior at a training center in Hefei, Anhui…
‘Hormuz moment’ could herald decline of US dominance: Citic Securities analysts
With global attention fixed on the US and Iranian shipping blockades in the Strait of Hormuz and how…
China’s PBOC keeps 1-year and 5-year benchmark lending rates unchanged
BEIJING, CHINA – DECEMBER 22: A woman walks by the headquarters of the People’s Bank of China (PBOC)…
Beijing half-marathon shows how far robots have come
BEIJING, CHINA – APRIL 19: A humanoid robot runs alongside participants during a long-distance race, breaking the half…
As China’s biotech firms shift gears, can AI floor the accelerator?
A quarter featuring multiple eye-popping deals is no longer unusual for China’s pharmaceutical industry – in fact, it…